Jonathan Silverstein insider trades: Arcutis Biotherapeutics (ARQT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jonathan reports to the SEC
and 7 more companies
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 2, 2020 | ARQT | ↑ Buy | 496,000 | $25.00 | $12.4M | Indirect | Oct 6, 2020 (4d) |
| Feb 3, 2020 | ARQT | ↑ Buy | 558,888 | $17.00 | $9.5M | Indirect | Feb 4, 2020 (1d) |
| Mar 6, 2018 | GKOS | ↓ Sell | 836,500 | $32.02 | $26.8M | Indirect | Mar 6, 2018 (0d) |
| Jan 30, 2018 | TORC | ↑ Buy | 533,333 | $15.00 | $8.0M | Indirect | Jan 30, 2018 (0d) |
| Sep 5, 2017 | GKOS | ↓ Sell | 580,200 | $38.73 | $22.5M | Indirect | Sep 5, 2017 (0d) |
| Aug 17, 2017 | GKOS | ↓ Sell | 325,000 | $37.93 | $12.3M | Indirect | Aug 17, 2017 (0d) |
| Mar 14, 2017 | GKOS | ↓ Sell | 382,538 | $45.33 | $17.3M | Indirect | Mar 14, 2017 (0d) |
| Mar 3, 2017 | GKOS | ↓ Sell | 55,772 | $47.05 | $2.6M | Indirect | Mar 7, 2017 (4d) |
| Aug 12, 2016 | GKOS | ↓ Sell | 292,938 | $33.69 | $9.9M | Indirect | Aug 12, 2016 (0d) |
| Aug 3, 2016 | GKOS | ↓ Sell | 425,000 | $30.59 | $13.0M | Indirect | Aug 5, 2016 (2d) |
| Jul 25, 2016 | BOLD | ↑ Buy | 33,334 | $15.00 | $500K | Indirect | Jul 25, 2016 (0d) |
| Mar 26, 2015 | ICPT | ↓ Sell | 157,200 | $286.75 | $45.1M | Indirect | Mar 30, 2015 (4d) |
| Mar 25, 2015 | ICPT | ↓ Sell | 207,800 | $274.41 | $57.0M | Indirect | Mar 25, 2015 (0d) |
| Aug 26, 2014 | ICPT | ↓ Sell | 111,258 | $298.06 | $33.2M | Indirect | Aug 27, 2014 (1d) |
| Aug 14, 2014 | ICPT | ↓ Sell | 60,000 | $299.82 | $18.0M | Indirect | Aug 18, 2014 (4d) |
| Jul 22, 2014 | ROKA | ↑ Buy | 383,333 | $12.00 | $4.6M | Indirect | Jul 24, 2014 (2d) |
| Apr 9, 2014 | ICPT | ↓ Sell | 81,305 | $320.00 | $26.0M | Indirect | Apr 11, 2014 (2d) |
| Nov 20, 2013 | RLYP | ↑ Buy | 712,192 | $11.00 | $7.8M | Indirect | Nov 20, 2013 (0d) |
| Oct 21, 2013 | ICPT | ↓ Sell | 40,088 | $62.50 | $2.5M | Indirect | Oct 23, 2013 (2d) |
| Oct 15, 2013 | ICPT | ↓ Sell | 376,585 | $62.50 | $23.5M | Indirect | Oct 17, 2013 (2d) |
| Oct 16, 2012 | ICPT | ↑ Buy | 333,334 | $15.00 | $5.0M | See Foonote | Oct 16, 2012 (0d) |
| May 31, 2006 | AVNR | ↓ Sell | 629,121 | $9.79 | $6.2M | See | Jun 7, 2006 (7d) |
| Oct 20, 2005 | AVN | ↑ Buy | 566,038 | $2.65 | $1.5M | by LLC | Oct 24, 2005 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ARQT insiders
Open-market trades in the last 12 months
About Jonathan Silverstein's insider trades
Jonathan Silverstein is a director at Arcutis Biotherapeutics (ARQT). Since Oct 20, 2005, Jonathan has reported 8 open-market purchases worth $49.3M and 15 sales worth $315.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (20 filings), conversions (10 filings), option exercises (9 filings), other transactions (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARQT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.